Unlock this StockReport nowClick to Unlock

Bioton SA

BIO PLN5.16 -0.2  -4.1%
15/01/19

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
12m Forecast Rolling
PE Ratio (ttm) 102.9
PEG Ratio (ttm)
EPS Growth (ttm) %
Dividend Yield (ttm) %
Valuation (ttm)
Price to Book Value 0.54
Price to Tang. Book
Price to Free Cashflow
Price to Sales
EV to EBITDA
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 TTM 2018E 2019E CAGR / Avg
Revenue PLNm
Operating Profit PLNm
Net Profit PLNm
EPS Reported PLN
EPS Normalised PLN
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps PLN
Capex ps PLN
Free Cashflow ps PLN
Dividends
Dividend ps PLN
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc PLNm
Working Capital PLNm
Net Fixed Assets PLNm
Net Debt PLNm
Book Value PLNm
Average Shares m
Book Value ps PLN -9.1%

FINANCIAL BRIEF: For the six months ended 30 September 2018, BIOTON SA revenues decreased 27% to PLN117.4M. Net loss before extraordinary items decreased 99% to PLN108K. Revenues reflect Scigen Group segment decrease of 60% to PLN27.9M, Insulin (Bioton SA) segment decrease of 1% to PLN89.5M, South Korea segment decrease of 57% to PLN15.9M, Australia segment decrease of 60% to PLN8.6M, Thailand segment decrease of 75% to PLN1.8M. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
B+
B+
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 30th Sep '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2018
31st Dec 2019

Price Target: N/A
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (PLN) (PLN) (PLN) (PLN) (PLN) (PLN)
Consensus Estimate
1m Change
3m Change
Broker Consensus Trend
Broker Recommendations for Bioton SA
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
Erste Group ,

Profile Summary

Bioton SA is a Poland-based company active in the pharmaceutical sector. The Company is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The Company's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.

Directors: Jubo Liu (CSU) , Robert Neymann (CMG) , Dariusz Trzeciak (VSU) , Vaidyanathan Viswanath (VSU) , Marek Dziki (MGB) 55, Boguslaw Kocinski (MGB) , Adam Polonek (MGB) , Qi Bo (SUB) , Mark Chiang (SUB) , Gary He (SUB) ,

No. of Employees: 712 No. of Shareholders: n/a


Last Annual December 31st, 2017
Last Interim September 30th, 2018
Incorporated August 2, 2004
Public Since March 16, 2005
Shares in Issue 85,864,200
Free Float 38.9m (45.3%)
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Warsaw Stock Exchange
Eligible for an ISA? a SIPP?

BIO Share Price Performance BIOQuote
PLN5.16
-0.2  -4.1%
Traded 4:35pm · Minimum 15 min delayed · NMS:

Latest BIO News Announcements (delayed)

Upcoming BIO Events
Tuesday 11th June, 2019 (estimate)
Bioton SA Annual Shareholders Meeting

Recent ↓
Wednesday 14th November, 2018
Bioton SA Extraordinary Shareholders Meeting
Wednesday 26th September, 2018
Bioton SA Extraordinary Shareholders Meeting
Monday 11th June, 2018
Bioton SA Annual Shareholders Meeting
Friday 12th January, 2018
Bioton SA Extraordinary Shareholders Meeting
Friday 29th September, 2017
Bioton SA Annual Shareholders Meeting
Thursday 22nd June, 2017
Bioton SA Annual Shareholders Meeting
Monday 15th May, 2017
Bioton SA Extraordinary Shareholders Meeting
Monday 23rd May, 2016
Bioton SA Annual Shareholders Meeting
Monday 22nd February, 2016
Bioton SA Extraordinary Shareholders Meeting
Wednesday 29th July, 2015
Bioton SA Annual Shareholders Meeting
Sunday 29th June, 2014
Bioton SA Annual Shareholders Meeting


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.


Should you buy BIO

Access BIO Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis